Health/Healthcare

Subcategories:
Biotechnology Reproductive Rights	Main Category List

---

Bitter Medicine
Two books on the (big) business of the pharmaceutical industry.
Reviewed By Shannon Brownlee
September/October 2004 Issue

Whose Hospital Is It?
MCP Hospital didn't have any celebrity doctors or slick ad campaigns. All it had was a 150-year history serving its Philadelphia neighborhood--and in today's cutthroat health care industry, that's no longer enough.
By Arthur Allen
May/June 2004 Issue

Medicare's Hidden Bonanza
After millions in campaign contributions, an insurance magnate's 10-year lobbying campaign finally pays off.
By Michael Scherer
March/April 2004 Issue

Toxic Tipping Point
Are the CDC, the FDA, and other health agencies covering up evidence that a mercury preservative in children's vaccines caused a rise in autism?
By Andrea Rock
March/April 2004 Issue

The Patient Predator
Tuberculosis is back, and thanks to globalization and slipshod treatment, it's deadlier than ever.
By Kevin Patterson
March/April 2003 Issue

Half an Ounce of Healing
The desperately ill members of a Santa Cruz marijuana club aren't growing pot to get high or make money. They just want to find some relief.
By Evelyn Nieves
January/February 2001 Issue

Forced Labor
Why are obstetricians speeding deliveries with an ulcer drug that endangers mothers and their babies?
By David Goodman
2001-01-01 issue
Who Owns My Disease?
In the scramble to patent human genes, companies have put profits ahead of patients' needs. Now some families with congenital diseases are staking a claim on the genetics revolution-and their own DNA.
By Arthur Allen
November/December 2001 Issue

Surgical Strike
Is a group that pays addicts to be sterilized defending children or exploiting the vulnerable?
By Barry Yeoman
November/December 2001 Issue

A Time for Healing
African Americans now account for the majority of new AIDS cases. But a crusading Harlem pastor believes the black church can slow the epidemic's spread.
By Jacob Levenson
July/August 2000 Issue

System Failure
The chemical revolution has ushered in a world of changes. Many of them, it's becoming clear are in our bodies.
By Jon R. Luoma
July/August 1999 Issue

Hitting the Wall
After 20 years of domestic violence research, scientists can't avoid hard facts.
By Nancy Updike
May/June 1999 Issue

More Work, More Play
Your kid puts in 9 to 5 at a daycare center. New research says that could be the best thing for her.
By Deborah Blum
March/April 1999 Issue

The Hard Body Sell
The cosmetic surgery industry has long preyed on women's body-image insecurities. Now it's targeting the other 49 percent.
By Laura Fraser
March/April 1999 Issue

Attention Deficit
Physical and sexual child abuse grab all the headlines. But what you may not realize is that neglect can be worse.
By Deborah Blum
January/February 1999 Issue

The Abortion Pill's Grim Progress
Anti-abortion protesters, gun-shy drug companies, and timid politicians have stymied RU 486 for a decade. This year, all that may change.
By Laura Fraser
January/February 1999 Issue

Implanted Evidence
The medical establishment has misread the data. Breast implants are still dirty.
By Michael Castleman
January/February 1998 Issue

Cold Comfort
Doctors know antibiotics don't offer relief from cold symptoms. So why do they still prescribe them?
By Michael Castleman
March/April 1998 Issue

Fetal Positions
In the debate over cloning, it's still pro-choice vs. pro-life. It shouldn't be.
By William Saletan
May/June 1998 Issue

Sunscam
Think sunscreen protects against cancer? Think again.
By Michael Castleman
May/June 1998 Issue

The Other Drug War
The FDA is wasting its time impeding harmless rice imports while ignoring what may be the fourth-leading cause of death.
By Michael Castleman
November/December 1998 Issue

The .02 Percent Solution
While critics call homeopathy 'utter nonsense,' two studies may give the alternative medical practice some scientific validity. By Michael Castleman
September/October 1998 Issue

Liver Let Live
A natural remedy for liver disease has been ignored by mainstream medicine.
By Michael Castleman
November/December 1997 Issue

Killer Bug Killers
Flea collars and no-pest strips may be toxic to kids as well as insects.
By Michael Castleman
September/October 1997 Issue

Hormonious Heart
Hormone replacement therapy helps prevent heart disease- a major killer.
By Michael Castleman
July/August 1997 Issue

Becoming Unblued
Move over Prozac. Try cognitive therapy for a drug-free way to treat depression.
By Michael Castleman
May/June 1997 Issue

A Life in Smoke
How cigarettes work on your body as they destroy it.
By Michael Castleman
May/June 1996 Issue

Legalize It!
Garlic reduces cholesterol. Ginger prevents motion sickness. Goldenseal is an antibiotic. Why do FDA regulations prohibit labels from saying so?
By Michael Castleman
November/December 1994 Issue

Breast Cancer and Environment
Environmental toxins may be causing the big rise in breast cancers. Why do scientists ignore them?
By Michael Castleman
May/June 1994 Issue

Surgeon General's Warning
Guns are hazardous to your health
Joycelyn Elders Interviewed By Ken Kelly
January/February 1994 Issue

Cutting Care
At the heart of the Clinton health plan is reliance on insurers to cut costs. That puts them in charge of deciding on the care you'll receive. A look at existing HMOs is not encouraging.
By Suzanne Gordon & Judy Shindul-Rothschild
January/February 1994 Issue

Beach Bummer
New evidence suggests that sunscreens don't prevent skin cancer and may even promote some forms of it. The manufacturers know it. Some researchers know it. Why don't consumers?
By Michael Castleman
May/June 1993 Issue

The Big Idea
Managed competition moved to the top of the president's health-care agenda despite broad popular support for a single-payer system. What is it, who's pushing it, and why?
By Robert Dreyfuss
May/June 1993 Issue

Alain Enthoven: The Godfather of Managed Competition
By Priscilla Yamin and Robert Dreyfuss
May/June 1993 Issue

Woman: The Disease
Women patients are where the money is.
By Charles Inlander
May/June 1993 Issue

The Smart Patient
Six major medical abuses--and what you can do to correct them.
By Charles Inlander
May/June 1993 Issue

A Social Disease
Dr. Mark Rosenberg thinks violence, like smallpox, can be prevented. But reactions to his idea have been, well, violent.
By Richard Blow
May/June 1993 Issue

Double-Dipping Doctors
T2 Medical approached doctors with a simple offer; refer your patients to us and we'll give you a big piece of the action. Now T2 is the eighteenth fastest-growing U.S. company.
By Steven Sternberg
May/June 1993 Issue

Doors of Memory
Over the past several years, psychotherapists have helped thousands of people discover repressed memories of childhood sexual abuse. What is more disturbing still is that many of these memories may be false.
By Ethan Watters
January/February 1993 Issue

Monsanto vs. the Milkman
A Maine dairy fights for the right to wear its hormone-free label.
By Susan Q. Stranahan
January/February 2004 Issue

A Cure for the Common Farm?
Genetically engineered 'pharmacrops' could be a curse for the Corn Belt -- or the family farm's last hope.
By Lucinda Fleeson
March/April 2003 Issue

Biotech's Black Market
An agricultural mystery in India has set off concerns over a growing underground trade in genetically engineered seeds.
By Douglas McGray
September/October 2002 Issue

Seeds of Secrecy The Mexican government has tried to silence scientists who discovered genetically modified corn where it doesn't belong.
By Kristi Coale
May/June 2002 Issue

Growing Resistance
Is agribusiness squandering one of medicine's most potent weapons?
By Edwin Dobb
November/December 2000 Issue

Same Great Taste? By George B. Sanchez
November/December 2001 Issue

A Biodefense Boondoggle
As pharmaceutical companies line up for multimillion-dollar contracts to make bioterrorism vaccines, some question whether the industry is up to the job.
By Bill Hogan
January/February 2002 Issue An Engineered Controversy
Farmers fear that genetically altered tobacco will contaminate their crops.
By Jane Akre
January/February 2002 Issue

People 2.0
Editor's Note
By Jeffrey Klein
May/June 1998 Issue

The New You: A Special Biotechnology Report
As corporations buy up stock in the human body, they also determine our future.
May/June 1998 Issue

An Owners' Guide
Pharmaceutical companies are mining your DNA for scientific gold.
By Hope Shand
May/June 1998 Issue

Patent Pending
Consumer-driven science and the new eugenics.
By Jeremy Rifkin
May/June 1998 Issue

Where New Genes Come From
By Hope Shand
May/June 1998 Issue

Next Year's Model
Imagining consumer-driven genetics.
By Ana Marie Cox and Kerry Lauerman
May/June 1998 Issue

Iceland's Blond Ambition
A Nordic country cashes in on its isolated gene pool.
By Eliot Marshall
May/June 1998 Issue

Regulating the Researchers
Does a ban on public funding mean a ban on public knowledge?
By Rachel Burstein
May/June 1998 Issue

A Growing Concern
As biotech crops come to market, neither scientists -- who take industry money -- nor federal regulators are adequately protecting consumers and farmers.
By Susan Benson, Mark Arax and Rachel Burstein
January/February 1997 Issue Flavor Saved?
Genetically engineered foods are in the supermarket now, and more are coming soon.
By Susan Benson and Leora Broydo
January/February 1997 Issue

No Way Around Roundup
Monsanto's bioengineered seeds are designed to require more of the company's herbicide.
By Mark Arax and Jeanne Brokaw
January/February 1997 Issue

Paid Protection
Why Monsanto and other industry giants love EPA regulations.
By Rachel Burstein
January/February 1997 Issue

Christian Science?
Siding with an antiabortion doctor, the FDA rejects easy access to a morning-after pill.
By Chris Mooney
September/October 2004 Issue

The Way It Was
The Beatles ruled. The mini was in. I was seventeen and pregnant. What happened next is what could happen again.
By Eleanor Cooney
September/October 2004 Issue

End of the Road
In the twilight of his career, one of the oldest living late-term abortion doctors tells all.
By Rebecca Paley
September/October 2003 Issue

The Fetal Position
Federal and state dollars are subsidizing a boom in antiabortion 'crisis pregnancy centers.'
By Ziba Kashef
January/February 2003 Issue

Antiabortion Ambush
Is putting photos of abortion-clinic patients on the Web an invasion of privacy? Or protected free speech?
By Sarah Schmidt
May/June 2002 Issue

The Quiet War on Abortion
After decades of noisy protests and violence, anti-abortion activists are relying on a new 'stealth strategy' to shut down clinics.
By Barry Yeoman
September/October 2001 Issue

The Abortion Pill's Grim Progress
Anti-abortion protesters, gun-shy drug companies, and timid politicians have stymied RU 486 for a decade. This year, all that may change.
By Laura Fraser
January/February 1999 Issue

Fetal Positions
In the debate over cloning, it's still pro-choice vs. pro-life. It shouldn't be.
By William Saletan
May/June 1998 Issue

Gloria Feldt, President of Planned Parenthood
The new president of Planned Parenthood misses the old Hillary Clinton and says "thanks" to Newt Gingrich, but "thanks for nothing" to the Democratic leadership.
Interviewed By Evan Smith
March/April 1997 Issue

Abortion's Risk
Pro-choice groups should not fall into the trap of defending abortion as absolutely safe -- it may not be.
By Michael Castleman
March/April 1995 Issue

The Choices
Methotrexate may be a new alternative to surgical abortion. I was the second person to try it.
By D. Redman
January/February 1994 Issue

An Alternative to RU486?
By Kim Hecht
January/February 1994 Issue

Both Sides From The Inside
Go to church, get busted, then cross over to help devend a clinic--it's all in a day's work for our reporter as he covers the violent war over abortion.
By Bill Dedman
November/December 1993 Issue

Defend the Moral High Ground
The national debate over abortion is not, in fact, a clash of absolutes.
By Kathleen Quinn
November/December 1993 Issue

Still Ticking ...
The Vatican's dark marriage to Islam has kept birth control off the international agenda. Meanwhile, the population bomb is still ticking.
By Mark Hertsgaard
March/April 1993 Issue